Compare HFFG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HFFG | NTRB |
|---|---|---|
| Founded | 1997 | 2016 |
| Country | United States | United States |
| Employees | 960 | N/A |
| Industry | Food Distributors | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.2M | 72.6M |
| IPO Year | 2016 | 2019 |
| Metric | HFFG | NTRB |
|---|---|---|
| Price | $1.52 | $6.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.67 | N/A |
| AVG Volume (30 Days) | ★ 41.1K | 24.4K |
| Earning Date | 11-09-2026 | 12-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.65 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,228,282,000.00 | $2,036,651.00 |
| Revenue This Year | $4.25 | $4,584.65 |
| Revenue Next Year | $5.60 | $89.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.21 | N/A |
| 52 Week Low | $1.38 | $2.80 |
| 52 Week High | $2.79 | $9.19 |
| Indicator | HFFG | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 54.08 | 47.26 |
| Support Level | $1.40 | $5.54 |
| Resistance Level | $1.97 | $6.66 |
| Average True Range (ATR) | 0.06 | 0.40 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 92.31 | 48.73 |
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, frozen and dry food, and non-food products to Asian restaurants and other foodservice customers throughout the United States. The company's business consists of one operating segment: HF Group, which operates solely in the United States. The company's product list consists of Meat, Poultry & Seafood, Sauces & Oils, Takeout Items (Boxes, Chopsticks & Utensils), Raw Ingredients (Flour, Cornstarch, Spices), Cleaning Supplies, and Rice & Grains.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.